| Typicality: | 0.245 |
| Saliency: | 0.193 |
| further | 9 | manner |
| in kidney cancer | 4 | other |
| in gist | 3 | other |
| trial → support → the research | 7 |
| trial → support → finding | 3 |
| negative | neutral | positive |
| 0.150 | 0.169 | 0.681 |
| Raw frequency | 10 |
| Normalized frequency | 0.193 |
| Modifier score | 0.500 |
| Perplexity | 133.449 |